Page 2 - புஜிஃபில்ம் வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Reddy s terminates COVID-19 treatment study in Kuwait

Data from the Kuwait trial, conducted in partnership with United Arab Emirates-based medical alliance Global Response Aid FZCO (GRA), showed that the difference in time taken by Avigan and placebo to resolve a sustained absence of oxygen in the tissues was not significant enough to continue the trial.

United statesFujifilm holdingGlobal response aidNorth americanCovid 19Dr reddy sஒன்றுபட்டது மாநிலங்களில்புஜிஃபில்ம் வைத்திருத்தல்உலகளாவிய பதில் உதவிவடக்கு அமெரிக்கன்டாக்டர் சிவப்பு கள்

India s Dr Reddy s ends study of COVID-19 drug Avigan in Kuwait

India s Dr.Reddy s ends study of COVID-19 drug Avigan in Kuwait Reuters 27/01/2021 © Reuters/Issei Kato FILE PHOTO: Tablets of Avigan are displayed during a photo opportunity at Fujifilm s headquarters in Tokyo BENGALURU (Reuters) - Indian drugmaker Dr.Reddy s Laboratories said on Wednesday it had terminated its clinical study of Fujifilm Holdings COVID-19 treatment Avigan in patients with moderate to severe symptoms in Kuwait. Data from the Kuwait trial, conducted in partnership with United Arab Emirates-based medical alliance Global Response Aid FZCO (GRA), showed that the difference in time taken by Avigan and placebo to resolve a sustained absence of oxygen in the tissues was not significant enough to continue the trial. (https://bit.ly/3onNbij)

United statesAmy caren danielAnuron kumar mitraFujifilm holdingJapanese health ministryGlenmark pharmaceuticalsIssei katoUnited arab emirates basedGlobal response aidAppili therapeuticsNorth americanஒன்றுபட்டது மாநிலங்களில்ஆமி கவனிப்பு டேனியல்புஜிஃபில்ம் வைத்திருத்தல்ஜப்பானிய ஆரோக்கியம் அமைச்சகம்க்ளேண்மர்க் மருந்துகள்

Dr Reddy s Completes Review Of Covid-19 Drug Avigan In Kuwait

Avigan was approved as an anti-flu drug in Japan in 2014. Drug major Dr. Reddy s Laboratories said on Wednesday it had terminated its clinical study of Fujifilm Holdings Covid-19 treatment Avigan in patients with moderate to severe symptoms in Kuwait. Dr. Reddy s Laboratories is an Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana. Data from the Kuwait trial, conducted in partnership with United Arab Emirates-based medical alliance Global Response Aid FZCO (GRA), showed that the difference in time taken by Avigan and placebo to resolve a sustained absence of oxygen in the tissues was not significant enough to continue the trial.

United statesAndhra pradeshFujifilm holding covidGlenmark pharmaceuticalsNational stock exchangeAvigan in kuwaitFujifilm holdingUnited arab emirates basedGlobal response aidAppili therapeuticsNorth americanஒன்றுபட்டது மாநிலங்களில்ஆந்திரா பிரதேஷ்க்ளேண்மர்க் மருந்துகள்தேசிய ஸ்டாக் பரிமாற்றம்புஜிஃபில்ம் வைத்திருத்தல்

Dr Reddy s terminates clinical study of COVID-19 treatment in Kuwait

Dr Reddy s terminates clinical study of COVID-19 treatment in Kuwait
inshorts.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inshorts.com Daily Mail and Mail on Sunday newspapers.

United statesFujifilm holdingGlobal response aidNorth americanஒன்றுபட்டது மாநிலங்களில்புஜிஃபில்ம் வைத்திருத்தல்உலகளாவிய பதில் உதவிவடக்கு அமெரிக்கன்

Japan review of Avigan says efficacy for COVID-19 treatment inconclusive: Report

Japan review of Avigan says efficacy for COVID-19 treatment inconclusive: Report Toggle share menu Advertisement Japan review of Avigan says efficacy for COVID-19 treatment inconclusive: Report FILE PHOTO: Fujifilm Holdings logos are pictured ahead of its news conference in Tokyo, Japan Jan 31, 2018. (Photo: REUTERS/Kim Kyung-Hoon) 17 Dec 2020 10:23AM Share this content Bookmark TOKYO: Japanese health authorities say it is difficult to determine the efficacy of Fujifilm Holdings antiviral drug Avigan as a treatment for COVID-19, Kyodo News reported on Thursday (Dec 17). Fujifilm has been seeking approval for the drug in Japan since October after its late-stage study showed faster recovery time for patients with non-severe symptoms.

United statesFujifilm holdingDevices agencyKyodo newsMedical devices agencyஒன்றுபட்டது மாநிலங்களில்புஜிஃபில்ம் வைத்திருத்தல்கியோடோ செய்தி